Saturday 7 November 2026 Export AMRX’s income statement to Excel — free account

AMNEAL PHARMACEUTICALS, INC.

AMRX Healthcare Drug Manufacturers Specialty & Generic

AMNEAL PHARMACEUTICALS, INC.’s revenue for fiscal 2025 (year ended December 2025) was $3.0 billion, up 8.05% from fiscal 2024.

Revenue: +9.96%
EPS: +267.0%
Free cash flow: −50.9%
Total debt: +23.8%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

20.11 0.66 +3.39%

Follow AMRX

Alert me

Market cap: $6.8B
P/E: 38.2×
Fwd P/E: 44.2×
Dividend yield: —
F-score: 7/9
Altman Z: 1.94
Beneish M: −2.68
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	7	7	7	6
ROE Full definition →		(79.69%)	(137.24%)	(395.84%)	(53,107.17%)
ROA Full definition →		2.01%	3.54%	4.37%	3.01%
ROIC Full definition →		11.25%	11.44%	11.05%	8.45%
Return on Tangible Assets Full definition →		4.89%	8.06%	10.35%	8.61%
Average Days of Receivables Full definition →		108.29	102.02	119.51	116.35
Free Cash Flow per Share Full definition →		0.73	0.60	(0.04)	(0.18)
Free Cash Flow Full definition →		227.73	189.67	(11.59)	(60.46)
Capital Expenditures Full definition →		(112.26)	(116.17)	(212.37)	(241.09)
Other line items
Cash ROIC Full definition →		8.10%	6.82%	(0.41%)	(1.56%)
Accounts Receivable Turnover Full definition →		3.61	3.79	3.41	3.35
Accounts Payable Turnover Full definition →		2.55	2.89	2.73	2.51
Inventory Turnover Full definition →		3.13	3.01	2.94	2.89
Average Days of Payables Full definition →		145.83	129.52	139.15	150.76
Days of Inventory on Hand Full definition →		116.14	125.35	130.81	135.30
Tax Rate Full definition →		(0.08)	0.00	0.07	(0.05)
Research and Development Expense of Revenue Full definition →		6.17%	6.06%	5.63%	5.65%
Selling, General and Administrative Expense of Revenue Full definition →		17.45%	17.97%	18.34%	17.95%
Share Based Compensation of Revenue Full definition →		1.06%	1.10%	1.14%	1.19%
Interest Coverage Full definition →		1.63	1.83	2.00	2.14
Operating CF/Net income Full definition →		4.72	2.50	1.28	1.36
Depreciation/Fixed assets Full definition →		0.56	0.51	0.46	0.37
Capex/Depreciation Full definition →		(0.46)	(0.51)	(1.01)	(1.15)
Revenue per Share Full definition →		9.63	9.64	9.77	9.52
Operating CF per Share Full definition →		1.09	0.97	0.63	0.54
Capex per Share Full definition →		(0.36)	(0.37)	(0.67)	(0.72)
Capex to Sales Full definition →		0.04	0.04	0.07	0.08

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly